We are live on ! Find out more
SIM

Spark Investment Management Portfolio holdings

AUM $41.6M
1-Year Est. Return 80.97%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+80.97%
3 Year Est. Return
+336.74%
5 Year Est. Return
+318.26%
10 Year Est. Return
+1,447.76%
AUM
$716M
AUM Growth
-$455K
Cap. Flow
+$5.83M
Cap. Flow %
0.81%
Top 10 Hldgs %
9.92%
Holding
851
New
153
Increased
123
Reduced
163
Closed
191

Top Buys

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$5.66M
2
GIMO
Gigamon Inc.
GIMO
+$4.46M
3
SONC
Sonic Corp
SONC
+$3.7M
4
CDK
CDK Global, Inc.
CDK
+$3.56M
5
APTV icon
Aptiv
APTV
+$3.19M

Top Sells

Rank Stock Value
1
ARUN
ARUBA NETWORKS, INC.
ARUN
+$5.17M
2
ABBV icon
AbbVie
ABBV
+$4.29M
3
OCUL icon
Ocular Therapeutix
OCUL
+$3.67M
4
LRMR icon
Larimar Therapeutics
LRMR
+$2.88M
5
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 20.73%
2 Healthcare 19.83%
3 Consumer Discretionary 15.89%
4 Industrials 11.34%
5 Energy 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTK
751
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-14,100
Closed -$434K
ISEE
752
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-18,900
Closed -$879K
AUD
753
DELISTED
Audacy, Inc.
AUD
– –
-12,700
Closed -$154K
BIOC
754
DELISTED
Biocept, Inc.
BIOC
– –
-8
Closed -$492K
AGRX
755
DELISTED
Agile Therapeutics
AGRX
– –
-13
Closed -$231K
APEN
756
DELISTED
Apollo Endosurgery, Inc.
APEN
– –
-200
Closed -$36K
SRNE
757
DELISTED
Sorrento Therapeutics, Inc.
SRNE
– –
-13,300
Closed -$153K
REED
758
DELISTED
Reeds, Inc. Common Stock
REED
– –
-362
Closed -$101K
ABMD
759
DELISTED
Abiomed Inc
ABMD
– –
-11,500
Closed -$823K
FNHC
760
DELISTED
FedNat Holding Company Common Stock
FNHC
– –
-15,900
Closed -$485K
CCXI
761
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-35,700
Closed -$268K
RDUS
762
DELISTED
Radius Health, Inc.
RDUS
– –
-28,500
Closed -$1.17M
CALA
763
DELISTED
Calithera Biosciences, Inc
CALA
– –
-1,465
Closed -$480K
HSTO
764
DELISTED
Histogen Inc. Common Stock
HSTO
– –
-261
Closed -$369K
IIN
765
DELISTED
IntriCon Corporation
IIN
– –
-12,600
Closed -$99K
KRA
766
DELISTED
Kraton Corporation
KRA
– –
-11,900
Closed -$240K
VCRA
767
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
– –
-22,200
Closed -$220K
GTS
768
DELISTED
Triple-S Management Corporation
GTS
– –
-11,352
Closed -$214K
INOV
769
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
– –
-13,200
Closed -$398K
FLXN
770
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-24,600
Closed -$553K
USCR
771
DELISTED
U S Concrete, Inc.
USCR
– –
-13,700
Closed -$464K
PRAH
772
DELISTED
PRA Health Sciences, Inc.
PRAH
– –
-15,300
Closed -$440K
GNMK
773
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-32,700
Closed -$424K
IPHI
774
DELISTED
INPHI CORPORATION
IPHI
– –
-65,800
Closed -$1.17M
GEN
775
DELISTED
Genesis Healthcare, Inc.
GEN
– –
-66,500
Closed -$473K
29 30
31
32 33

Similar funds

ACM
Altium Capital Management New York $42M AUM
TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return

Spark Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Spark Investment Management held 851 positions worth $716M, down 0.06% from $716M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Spark Investment Management's Q2 2015 filing shows 153 new, 123 increased, 163 reduced and 191 closed positions. Its largest new stake was bluebird bio: 2,779 shares worth $6.06M. The largest sale was ARUBA NETWORKS, INC., an estimated $5.17M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Spark Investment Management's largest Q2 2015 buy was bluebird bio: 2,779 shares worth $6.06M.
  • Spark Investment Management added most to Gigamon Inc. in Q2 2015, an estimated $4.46M increase.
  • Spark Investment Management's biggest Q2 2015 reduction was Larimar Therapeutics, cutting an estimated $2.88M.
  • Spark Investment Management fully exited ARUBA NETWORKS, INC. in Q2 2015, selling an estimated $5.17M.
  • Spark Investment Management's ten largest holdings make up 9.9% of its $716M portfolio in Q2 2015.
  • Spark Investment Management opened 153 new positions and closed 191 in Q2 2015.
  • Spark Investment Management's portfolio value fell 0.06% quarter-over-quarter to $716M.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.